Levonorgestrel and ethinyl estradiol tablets usp 0.15 mg 0.03 mg

Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive COC use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked.

Levonorgestrel and ethinyl estradiol tablets USP are an extended-cycle oral contraceptive consisting of 84 pink active tablets each containing 0. The structural formulas are as follows:. Each white inert tablet contains the following inactive ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate and microcrystalline cellulose. Combination oral contraceptives act by suppression of gonadotropins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cervical mucus which increase the difficulty of sperm entry into the uterus and changes in the endometrium which reduce the likelihood of implantation. No specific investigation of the absolute bioavailability of levonorgestrel and ethinyl estradiol tablets in humans has been conducted. The effect of food on the rate and the extent of levonorgestrel and ethinyl estradiol absorption following oral administration of levonorgestrel and ethinyl estradiol tablets has not been evaluated.

Levonorgestrel and ethinyl estradiol tablets usp 0.15 mg 0.03 mg

Females using Chateal EQ may experience unscheduled breakthrough or intracyclic bleeding and spotting, especially during the first three months of use. Bleeding irregularities may resolve over time or by changing to a different contraceptive product. Females who use Chateal EQ may experience absence of scheduled withdrawal bleeding, even if they are not pregnant. If scheduled bleeding does not occur, consider the possibility of pregnancy. The most common side effects of oral contraceptives are nausea, vomiting, bleeding between menstrual periods, weight gain, breast tenderness, and difficulty wearing contact lenses. Combined oral contraceptives COCs increase the risk of cardiovascular and cerebrovascular events, such as myocardial infarction and stroke. Use of COCs increases the risk of venous thromboembolic events VTEs , such as deep vein thrombosis and pulmonary embolism. Learn more, including how to disable certain cookies on our Cookies Policy page. Click OK to continue. You are now leaving afaxyspharma. Links to sites outside of Afaxys are provided as a resource to the viewer. Afaxys, Inc. NDC Product Details Monophasic administration regimen 21 orange tablets of levonorgestrel and ethinyl estradiol 7 green placebo tablets to help ease administration Combined in a day tablet blister pack.

The box on the bottom of the chart shows the chance of getting pregnant for women who do not use birth control and are trying to get pregnant. It is very important that you use this medicine exactly as directed by your doctor. Throughout this labeling, epidemiological studies reported are of two types: retrospective or case control studies and prospective or cohort studies.

The photos shown are samples only Not all photos of the drug may be displayed. Your medication may look different. If you have questions, ask your pharmacist. Smoking raises your risk of stroke, heart attack, blood clots, and high blood pressure from hormonal birth control such as the pill, patch, ring. The risk of these serious problems increases with age and with the number of cigarettes you smoke.

Levonorgestrel and ethinyl estradiol tablets USP are an extended-cycle oral contraceptive consisting of 84 pink active tablets each containing 0. The structural formulas are as follows:. Each white inert tablet contains the following inactive ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate and microcrystalline cellulose. Combination oral contraceptives act by suppression of gonadotropins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cervical mucus which increase the difficulty of sperm entry into the uterus and changes in the endometrium which reduce the likelihood of implantation. No specific investigation of the absolute bioavailability of levonorgestrel and ethinyl estradiol tablets in humans has been conducted. The effect of food on the rate and the extent of levonorgestrel and ethinyl estradiol absorption following oral administration of levonorgestrel and ethinyl estradiol tablets has not been evaluated. The apparent volume of distribution of levonorgestrel and ethinyl estradiol are reported to be approximately 1. Levonorgestrel is about

Levonorgestrel and ethinyl estradiol tablets usp 0.15 mg 0.03 mg

It is very important that you use this medicine exactly as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. This medicine comes with patient instructions. Read and follow these instructions carefully.

Sweetbettyparlour

No formal studies have been conducted to evaluate the effect of hepatic disease on the pharmacokinetics of levonorgestrel and ethinyl estradiol tablets. It is important to take it at the same time every day and in the order as directed on your pill pack. This medication may interfere with certain lab tests such as blood clotting factors, thyroid , possibly causing false test results. However, pediatric-specific problems that would limit the usefulness of this medication in teenagers are not expected. The risk of thromboembolic disease due to oral contraceptives is not related to length of use and disappears after pill use is stopped. The above information is intended to supplement, not substitute for, the expertise and judgment of your health care professional. Five studies that compared breast cancer risk between ever-users current or past use of COCs and never-users of COCs reported no association between ever use of COCs and breast cancer risk, with effect estimates ranging from 0. Some other examples of serious blood clots include blood clots in the legs or eyes. This could result in unintended pregnancy or breakthrough bleeding. Women who currently have or have had breast cancer should not use oral contraceptives because breast cancer is a hormone sensitive tumor. For oral contraceptive users in general, it has been estimated that in women between the ages of 15 and 34 the risk of death due to a circulatory disorder is about 1 in 12, per year, whereas for nonusers the rate is about 1 in 50, per year. More recent studies, however, have shown that the relative risk of developing gallbladder disease among oral contraceptive users may be minimal.

.

Since scheduled menstrual periods are less frequent when you are taking levonorgestrel and ethinyl estradiol tablets, notify your healthcare provider that you have missed your period and are taking levonorgestrel and ethinyl estradiol tablets. US residents can call their local poison control center at INERT inert tablet. I AM A:. This type of bleeding may be transient and without significance; however, if the bleeding is persistent or prolonged, the patient is advised to consult her healthcare provider. However, steroid hormones may be poorly metabolized in patients with impaired liver function. Use an additional birth control method, like condoms or spermicide, until you check with your healthcare provider. The apparent volume of distribution of levonorgestrel and ethinyl estradiol are reported to be approximately 1. An additional method of contraception is not needed if levonorgestrel and ethinyl estradiol tablets are started immediately. The estrogen component of levonorgestrel and ethinyl estradiol tablets may raise the serum concentrations of thyroxine-binding globulin, sex hormone-binding globulin, and cortisol-binding globulin. You do not need back-up contraception if you use the Day 1 Start. Information last revised February Dose adjustment may be necessary. Your doctor may ask you to begin your dose on the first day of your menstrual period called Day 1 start or on the first Sunday after your menstrual period starts called Sunday start.